Abstract
Hepatic gene therapy may provide a new approach to treating hepatic malignancies. A promising strategy involves the infection of tumor and liver cells with replication-defective adenoviral vectors carrying suicide genes. The products of these genes convert prodrugs into cytotoxic derivates. In the transduced cells the subsequently administered prodrugs are thus activated and destroy replicating tumor cells, whereas the infected liver cells are thought to be unaffected because of their minimal proliferative activity. A major concern about this approach is that the suicide genes can theoretically enter the germline and other organs with high mitotic activity and as a consequence, cause their destruction. In vivo gene delivery should therefore be tissue-specific, and methods for targeted gene delivery are required. Targeting the colorectal liver metastases is pursued by combining the suicide gene principle and the surgical technique of isolated perfusion of the liver.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Caruso M, Panis Y, Cangadeep S, Houssin D, Salzmann JL, Klatzmann D (1993) Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proc Natl Acad Sci USA 90: 7024–7028
Chen C, Chang Y, Ryan P, Linscott M, McGarrity CJ, Chiang YL (1995) Effect of herpes simplex virus thymidine kinase expression levels on ganciclovir-mediated cytotoxicity and the “bystander” effect. Hum Gene Ther 6: 1467–1476
Chowdhury JR, Crossman M, Cupta S, Chowdury NR, Baker JR, Wilson JM (1991) Long- term improvement of hypercholesterolemia after in vivo gene therapy in LDLR-deficient rabbits. Science 254: 1802
Colombo BM, Benedetti S, Ottolenghi S, Mora M, Polio B, Poli C, Finocchiaro G (1995) The “bystander effect”: association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice. Hum Gene Ther 6: 763–772
Crystal RC, McElvaney NG, Rosenfield MA, Chu C, Mastrangeli A, Hay JG, Brody SL, Jaffe HA, Eisa NT, Danel C (1994) Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nature [Genet] 8: 42–51
Culver KW, Ram Z, Wallbridge S, Ishii II, Oldfield EH, Blaese RM (1992) In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256: 1550–1552
Danen-Van Oorschot AA, Fischer DF, Grimbergen JM, Klein B, Zhuang S, Falkenburg JH, Backendorf C, Quax PH, Van der Eb AJ, Noteborn MH (1997) Apoptin induces apoptosis in human transformed and malignant cells but not in normal cells. Proc Natl Acad Sci USA 94: 5843–5847
De Roos WK, Fallaux FJ, Marinelli AWKS, Lazaris-Karatzas A, Alting Von Geusau B, Van der Eb MM, Cramer SJ, Terpstra OT, Hoeben RC (1997) Isolated-organ perfusion for local gene delivery: efficient adenovirus-mediated gene transfer into the liver. Gene Ther 4: 55–62
Fallaux FJ, Hoeben RC, Briet E (1995) State and prospects of gene therapy for the hemophilias. Thromb Haemost 74: 263–273
Fallaux FJ, Kranenburg O, Cramer SJ, Houweling A, Van Ormondt H, Hoeben RC, Van der Eb AJ (1996) Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. Hum Gen Ther 7: 215–222
Freeman SM, Abboud CN, Whartenby KA, Packman CH, Koeplin DS, Moolten FL, Abraham GN (1993) The “bystander effect”: tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 53: 5274–5283
Galea-Lauri J, Gaken J (1996) Cancer Gene Therapy II: Immunomodulation strategies. In: Lemoine NR, Cooper DN (eds) Gene Therapy. BIOS Scientific publishers Ltd, Oxford, UK, pp 277–292
Graham FL, Van der Eb AJ (1973) A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52: 456–467
Crossman M, Raper SE, Kozarsky K, Stein EA, Engelhardt JF, Muller D, Lupien PJ, Wilson JM (1994) Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia. Nature [Genet] 6: 335–341
Kay MA, Rothenberg S, Landen CN, Bellinger DA, Leland F, Toman C, Finegold M, Thompson AR, Read MS, Brinkhous KM (1993) In vivo gene therapy of hemophilia B: sustained partial correction in factor IX-deficient dogs. Science 262: 117
Le Gal La Salle C, Robert JJ, Berrard S, Ridoux V, Stratford-Perricaudet LD, Perricaudet M, Mallet J (1993) An adenovirus vector for gene transfer into neurons and glia in the brain. Science 259: 988–990
Martin LA, Lemoine NR (1996) Direct cell killing by suicide genes. Cancer Metastasis 15: 301–316
Moolten FL (1986) Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res 46: 5276–5281
Nabel EG, Plautz GE, Nabel GJ (1994) Recombinant growth factor gene expression in vascular cells in vivo. Ann NY Acad Sci 714: 247–252
Naviaux RK, Verma IM (1992) Retroviral vectors for persistant expression in vivo. Curr Opin Biotechnol 3: 540–547
Nielsen LL, Maneval DC (1998) P53 tumor suppressor gene therapy for cancer. Cancer Gene Ther 5: 52–63
Qian C, Bilbao R, Bruña O, Prieto J (1995) Induction of sensitivity to ganciclovir in human hepatocellular carcinoma cells by adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase. Hepatology 22: 118–123
Quantin B, Perricaudet LD, Tajbakhsh S, Mandel J-L (1992) Adenovirus as an expression vector in muscle cells in vivo. Proc Nat Acad Sci USA 89: 2581–2584
Rosenfeld MA, Siegfried W, Yoshimura K, Yoneyama K, Fukayama M, Stier LE et al (1991) Adenovirus-mediated transfer of a recombinant ax antitrypsin gene to the lung epithelium in vivo. Science 252: 431–434
Smythe WR, Hwang HC, Amin KM, Eck SL, Davidson BL, Wilson JM, Kaiser LR, Albeda SM (1994) Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: an effective in vitro drug sensitization system. Cancer Res 54: 2055–2059
Thomas C, Nijenhuis AM, Timens W, Kuppen PJ, Dalmen T, Scherphof GL (1993) Liver metastases model of colon cancer in the rat: immunohistochemical characterization. Invasion Metastasis 13: 102–112
Van der Eb MM, Cramer SJ, Vergouwe Y, Schagen FHE, van Krieken JHJM, van der Eb AJ, Borel Rinkes IHM, van de Velde CJH, Hoeben RC (1998) Severe hepatic dysfunction after adenovirus-mediated transfer of the herpes simplex thymidine kinase gene and ganciclovir administration. Gene Therapy, in press
Vile RC (1994) Tumor-specific gene expression. Cancer Biol 5: 429–436
Wilson JM (1996) Round two for liver gene therapy. Nat Genet 12: 232–233
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
van der Eb, M.M., Hoeben, R.C., van de Velde, C.J.H. (1998). Towards Gene Therapy for Colorectal Liver Metastases. In: Oldhafer, K.J., Lang, H., Pichlmayr, R. (eds) Isolated Liver Perfusion for Hepatic Tumors. Recent Results in Cancer Research, vol 147. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80460-1_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-80460-1_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-80462-5
Online ISBN: 978-3-642-80460-1
eBook Packages: Springer Book Archive